American Regent, Inc.

PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT)

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) – J9259

Manufacturer:

American Regent, Inc.

Name:

PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT)

HCPCS Code Descriptor:

Injection, paclitaxel protein-bound particles (american regent) not therapeutically equivalent to j9264, 1 mg

Category:

J Code

HCPCS:

J9259

NDC(s):

00517-4300-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) is a Oncology drug manufactured by American Regent, Inc. and administered via the Intravenous route of administration. The J Code: J9259 is aligned to the drug PACLITAXEL PROTEIN-BOUND (AMERICAN REGENT) .

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/23

HCPCS Effective Date:

7/1/23

HCPCS Short Description:

Paclitaxel (american regent)

Billing and Coding Guide:

https://americanregent.com/media/3439/pp-pt-us-0013_billingcoding_gde_-v05-_20jun2023.pdf

Patient Assistance:

Not Found